Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?

Cancer investigation - 1 Oct 2008

Singh Virendra, Parmar Devendra, Singh Mahendra Pratap

Abstract excerpt

SNPs in CYP1A1, CYP2A1, CYP2B6, CYP2C, CYP2D6, CYP3A, GSTM1, GSTT1, GSTP1, SULT1A1, SULT1A2, UGT, and MTHFR are associated with breast cancer susceptibility; however, lack of such associations are also reported in some populations. The contradictory findings are explained on the basis of ethnic variation among populations and due to lack of proper sample size, detailed genotype-phenotype combinations and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biotransformation
Share to Cytochrome P-450 Enzyme System

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Glutathione Transferase

Share to Methylenetetrahydrofolate Reductase (NADPH2)

Share to Monosaccharide Transport Proteins

Share to Penetrance

Share to Sulfotransferases

Share to Xenobiotics

Source

Identifiers

PMID: 18798070
DOI: 10.1080/07357900801953196

Genes

GSTM1
GSTP1
GSTT1
MTHFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Do single nucleotide polymorphisms in xenobiotic metabolizing genes determine breast cancer susceptibility and treatment outcomes?PMID 18798070Read ↗

Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.Semantic proximity Read ↗

Meta-analysis of genetic polymorphisms in xenobiotic metabolizing enzymes and their association with breast cancer risk.Semantic proximity Read ↗

CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case-control study.Semantic proximity Read ↗

[Cancer pharmacogenetics: study of genetically determined variations on cancer susceptibility due to xenobiotic exposure].Semantic proximity Read ↗

Polymorphisms in GSTT1 and GSTM1 genes as possible risk factors for susceptibility to breast cancer development and their influence in chemotherapy response: a systematic review.Semantic proximity Read ↗

Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes.Semantic proximity Read ↗

Sulfotransferase genetic variation: from cancer risk to treatment response.Semantic proximity Read ↗

Polymorphisms in drug-metabolizing genes and urinary bladder cancer susceptibility and prognosis: Possible impacts and future management.Semantic proximity Read ↗

Role of cytochrome P450 genes in breast cancer etiology and treatment: effects on estrogen biosynthesis, metabolism, and response to endocrine therapy.Semantic proximity Read ↗

Single Nucleotide Polymorphisms as the Efficient Prognostic Markers in Breast Cancer.Semantic proximity Read ↗

Polymorphism of CYP450 and cancer susceptibility.Semantic proximity Read ↗

Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene PolymorphismsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.